Srini Akkaraju, M.D., Ph.D.

Founder & Managing Partner

Samsara BioCapital

Jeremy Caldwell, Ph.D.

Managing Director

Red Tree Venture Capital

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners

Alex Cogdill, MEng, Ph.D.

Head of Strategic Initiatives, Global Business Development

Daiichi Sankyo U.S.

Richard DiMarchi, Ph.D.

GLP-1 Biology Pioneer; Distinguished Professor, Indiana University

Jon Edwards, Ph.D.

Partner

Forbion

Rob Garbaccio, Ph.D.

SVP, Worldwide Head of Search & Evaluation and Science Strategy

Merck

Richard Glynne, Ph.D.

Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture Partner

Versant Ventures

Jeffrey Golden, M.D.

Director, Burns and Allen Research Institute & Executive Vice Dean for Research and Education

Cedars Sinai Medical Center

Corey Goodman, Ph.D.

Managing Partner

venBio Partners

Richard Heyman, Ph.D.

Venture Partner

ARCH Ventures

Tony Ho

Chief Scientific Officer & Senior Science Partner

Pivotal Life Sciences

Jeremy Jenkins

US Head Discovery Sciences

Novartis

Rachna Khosla

Senior Vice President, Business Development

Amgen

Deborah Law

Chief Scientific Officer

Xaira Therapeutics

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner

Flagship Pioneering

Tim Luker, Ph.D.

Vice President, Lilly Ventures, West Coast USA Head, Corp BD

Eli Lilly

Detlev Mennerich, Ph.D.

Global Head

Boehringer Ingelheim Venture Fund

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck

David Moller

Venture Partner

Third Rock Ventures

Nikhil Mutyal, Ph.D.

Head of Search & Evaluation, Respiratory & Immunology

AstraZeneca

Deborah Nguyen

Operating Partner

Red Tree Venture Labs

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative

5AM Ventures

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck

Andy Plump

President, Research & Development

Takeda Pharmaceutical Company Ltd.

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK

John Reed, M.D., Ph.D.

EVP, Pharmaceuticals, Research & Development

Johnson & Johnson Innovative Medicine

Peter Schultz, Ph.D.

President, CEO & Professor of Chemistry

Scripps Research

Avi Spier, Ph.D.

Executive Director, Search & Evaluation

Novartis

Stephen Squinto

Chief Investment Officer

J.P. Morgan Asset Management

R. Scott Struthers, Ph.D.

Co-Founder and Chief Executive Officer

Crinetics Pharmaceuticals

Yongkui Sun

Chairman & CEO

IONOVA Life Science

Marc Tessier-Lavigne, Ph.D.

Co-Founder, Chairman & CEO

Xaira Therapeutics

Nancy Thornberry

Founding CEO & Chair, R&D

Kallyope

Richard Tillyer, Ph.D.

Global Head, Discovery, Product Development & Supply

Johnson & Johnson Innovative Medicine

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories

Issei Tsukamoto, Ph.D.

SVP, Head of Business Development

Astellas Pharma

Jill Wykosky, Ph.D.

Venture Partner

Raven (RA Ventures)

Fan Zhang, Ph.D.

Vice President of Business Development

Bristol Myers Squibb